Cen Biotech Inc financial data

Location
300 3295 Quality Way, Windsor, Ontario, Canada
State of incorporation
Canada (Federal Level)
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 14, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.56 % +285%
Debt-to-equity -533 % -173%
Return On Equity 163 %
Return On Assets -37.6 % -211%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.1M shares
Common Stock, Shares, Outstanding 64M shares +33.9%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 64M shares +35.2%
Weighted Average Number of Shares Outstanding, Diluted 42.4M shares +53.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 136K USD -50.1%
General and Administrative Expense 17.3M USD +757%
Operating Income (Loss) -2.71M USD +84.6%
Nonoperating Income (Expense) -402K USD -102%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -259K USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -3.08M USD -234%
Earnings Per Share, Basic 0.09 USD/shares +50%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 148K USD -30.7%
Accounts Receivable, after Allowance for Credit Loss, Current 11.3K USD -93.1%
Assets, Current 301K USD -24.3%
Deferred Income Tax Assets, Net 2.72K USD
Property, Plant and Equipment, Net 68.7K USD -33.8%
Operating Lease, Right-of-Use Asset 95.4K USD -36.5%
Intangible Assets, Net (Excluding Goodwill) 4.82M USD -8.72%
Goodwill 1.28M USD +13.2%
Assets 7.91M USD -5.83%
Accounts Payable, Current 396K USD +39.4%
Accrued Liabilities, Current 379K USD -54.2%
Liabilities, Current 9.83M USD -9.6%
Operating Lease, Liability, Noncurrent 159K USD -28.9%
Liabilities 10M USD -12.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -35.8K USD +19.4%
Retained Earnings (Accumulated Deficit) -47M USD -7.05%
Stockholders' Equity Attributable to Parent -2.11M USD +31.6%
Liabilities and Equity 7.91M USD -5.83%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -58K USD +5.08%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares, Issued 64M shares +33.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -58K USD -5044%
Deferred Tax Assets, Valuation Allowance 8.3M USD +7.79%
Depreciation 9.95K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.9M USD +47.6%
Operating Lease, Liability, Current 115K USD +21.5%
Deferred Income Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 8.3M USD +7.79%
Additional Paid in Capital 44.9M USD +9.94%
Amortization of Intangible Assets 83.9K USD -21%
Deferred Tax Assets, Net of Valuation Allowance 0 USD